We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Procedure Allows Paralyzed Actor to Breathe Without Respirator

By HospiMedica staff writers
Posted on 27 Mar 2003
An experimental procedure whereby electrodes were implanted into the diaphragm of Christopher Reeve, the actor paralyzed by a fall and on a respirator for the last eight years, has allowed him to breathe without the respirator for more than two hours.

The doctors who performed the procedure, called diaphragm pacing via laparoscopy, say it may enable Mr. More...
Reeve to wean himself from the respirator permanently as the muscles in his diaphragm grow stronger over the next few months. The experimental procedure has the approval of the US Food and Drug Administration (FDA) to be used in 35 patients.

Mr. Reeve's phrenic nerves, which control breathing and extend from the spinal cord to the diaphragm, were not injured in his fall. However, because these nerves meet the spinal cord below the injury site, they could not receive signals from the brain stem, which initiates breathing. Doctors realized that artificial activation of these nerves might restore natural breathing.

In the new technique, wires extend from a control box outside the body to the implanted electrodes on the diaphragm. When current stimulates the electrodes, the diaphragm contracts, sucking air into the lungs. When stimulations stops, the diaphragm relaxes and the air moves out of the lungs. A signal is sent from the control box to the electrodes 12 times a minute, which approximates normal breathing rate. The procedure was performed by doctors at the Cleveland Clinic (OH, USA).




Related Links:
Cleveland Clinic

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.